Challenges of genomics and proteomics in nephrology genomics and proteomics in nephrology

Renal Failure

Volumn 31, Issue 8, 2009, Pages 765-772

  Stojnev, Slavica ^a   Pejcic, Miljana ^a   Dolicanin, Zana ^a   Velickovic, Ljubinka Jankovic ^a   Dimov, Irena ^a   Stefanovic, Vladisav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acute kidney injury; Biomarkers; Diabetic nephropathy; Genomics; Glomerulonephritis; Proteomics; Urinary proteome

Indexed keywords

ACUTE KIDNEY FAILURE; CELL FUNCTION; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; GENE ACTIVITY; GENE EXPRESSION; GENOMICS; HUMAN; KIDNEY CLEARANCE; KIDNEY INJURY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEOMICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UREMIA;

GENOMICS; HUMANS; KIDNEY DISEASES; NEPHROLOGY; PROTEOMICS;

EID: 70350668664     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903100713     Document Type: Review

References (53)

1. Mueller GA, Mueller CA, Dihazi H. Clinical proteomics-on the long way from bench to bedside. Nephrol Dial Transplant. 2007;22:1297-1300.
2. Gupta P, Lee KH. Genomics and proteomics in process development: Opportunities and challenges. Trends Biotechnol. 2007;25:324-330.
3. Lee PS, Lee KH. Genomic analysis. Curr Opin Biotechnol. 2000;11:171-175.
4. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D. Accessing genetic information with high density DNA arrays. Science. 1996;274:610-614.
5. Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature. 2000;405:827-836.
6. Beaudet AL, Belmont JW. Array-based DNA diagnostics: Let the revolution begin. Annu Rev Med. 2008;59:113-129.
7. Higgins JPT, Wang L, Kambham N, Montgomery K, Mason V, Vogelmann SU, et al. Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell. 2004;15:649-656.
8. Ritz E. Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002;13:2384-2398.
9. Hildebrandt F, Strahm B, Nothwang HG, Gretz N, Schnieders B, Singh-Sawhney I, et al. Molecular genetic identification of families with juvenile nephronophthisis type 1: Rate of progression to renal failure. Kidney Int. 1997;51:261-269.
10. Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Seddighzadeh M, Hahn-Zoric M, et al. Genetic variation in the transforming growth factor-b1.gene is associated with susceptibility to IgA nephropathy. Nephrol Dial Transplant. 2009, doi:10.1093/ndt/gfp079.
11. Yoon HJ, Chin HJ, Na KY, Chae DW, Kim S, Jeon US, et al. Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin a nephropathy in Korean patients. J Korean Med Sci. 2009; 24(Suppl. 1):s38-s43.
12. Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, Chae DW, et al. The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality. J Korean Med Sci. 2009;24 (Suppl. 1):s30-s37.
13. Caridi G, Bertelli R, Carrea A, Diduca M, Catarsi P, Artero M, et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol. 2001;12:2742-2746.
14. Pezzolesi MG, Poznik GD, Mychaleckyj JC, Paterson AD, Barati MT, Klein JB, et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes mellitus. Diabetes. 2009;58:1403-1410.
15. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia-reperfusion. Kidney Int. 2003;63:1714-1724.
16. Green DR, Kroemer G. Pharmacologic manipulation of cell death: Clinical applications insight? J Clin Invest. 2005;115: 2610-2617.
17. Jones J, Libermann TA. Genomics of renal cell cancer: The biology behind and the therapy ahead. Clin Cancer Res. 2007;13(Suppl. 2):s685-s692.
18. Kopper L, Timar J. Genomics of renal cell cancer-does it provide breakthrough? Pathol Oncol Res. 2006;12:5-11.
19. Peng J, Gygi SP. Proteomics: The move to mixtures. J Mass Spect. 2001;36:1083-1091.
20. Thongboonkerd V. Proteomics in nephrology: Current status and future directions. Am J Nephrol. 2004;24:360-378.
21. Knepper MA. Proteomics and the kidney. J Am Soc Nephrol. 2002;13:1398-1408.
22. Arthur JM. Proteomics. Curr Opin Nephrol Hypertens. 2003;12:423-430.
23. Dihazi H, Mueller GA. Urinary proteomics: A tool to discover biomarkers of kidney diseases. Proteomics. 2007;4: 39-50.
24. Fliser D, Novak J, Thongboonkerd V, Argilés À, Jankowski V, Girolami MA, et al. Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol. 2007;18: 1057-1071.
25. Arthur JM, Thongboonkerd V, Scherzer JA, Cai J, Pierce WM, Klein JB. Differential expression of proteins in renal cortex and medulla: A proteomic approach. Kidney Int. 2002;62:1314-1321.
26. Xu BJ, Shyr Y, Liang X, Ma LJ, Donnert EM, Roberts JD, et al. Proteomic patterns and prediction of glomerulosclerosis and its mechanisms. J Am Soc Nephrol. 2005;16: 2967-2975.
27. Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, et al. Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling. Cell. 2006;125:173-186.
28. Yoshida Y, Miyazaki K, Kamijo K, Tsugita A, Kamiie J, Xu B, et al. Proteome database of normal human glomerulus: Two-dimensional electrophoresis profiling and constructing of XML-based database. J Am Soc Nephrol. 2003; 14(Suppl.):283A.
29. Vidal BC, Bonventre JV, Hong SI. Towards the application of proteomics in renal disease diagnosis. Clin Science. 2005;109:421-430.
30. Decramer S, Wittke S, Mischak H, et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Met. 2006;12:398-400.
31. Schaub S, Wilkins J, Weiler T, et al. Urine protein profiling with surface-enhanced laser-desorption/ionization time-offlight mass spectrometry. Kidney Int. 2004;65:323-332.
32. Thongboonkerd V, McLeish KR, Arthur JM, Klein JB. Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 2002;62:1461-1469.
33. Pieper R, Gatlin CL, McGrath AM, Makusky AJ, Mondal M, Seonarain M, et al. Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 2004;4:1159-1174.
34. Sun W, Li F, Wu S, Wang X, Zheng D, Wang J, Gao Y. Human urine proteome analysis by three separation approaches. Proteomics. 2005;5:4994-5001.
35. Castagna A, Cecconi D, Sennels L, Rappsilber J, Guerrier L, Fortis F, et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res. 2005;4:1917-1930.
36. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol. 2006;7:R80.
37. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol. 2004;15: 1677-1689.
38. Zhou H, Pisitkun T, Aponte A, Yuen PS, Hoffert JD, Yasuda H, et al. Exosomal fetuin-A identified by proteomics: A novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006;70:1847-1857.
39. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:127-132.
40. Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, et al. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics. 2006;6:1066-1076.
41. Shui HA, Huang TZ, Ka SM, Chen PH, Lin YF, Chen A. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2008;23:176-185.
42. Haubitz M, Wittke S, Weissinger EM, Walden M, Rupprecht HD, Floege J, et al. Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy. Kidney Int. 2005;67:2313-2320.
43. Weissinger EM, Wittke S, Kaiser T, Haller H, Bartel S, Krebs R, et al. Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int. 2004;65:2426-2434.
44. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P, et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics. 2005;5:2648-2655.
45. Dihazi H, Mueller GA, Lindner S, Meyer M, Asif AR, Oellerich M, Strutz F. Characterization of diabetic nephropathy by urinary proteomic analysis: Identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem. 2007;53:1636-1645.
46. Wittke S, Haubitz M, Walden M, Rohde F, Schwarz A, Mengel M, et al. Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients. Am J Transplant. 2005;5:2479-2488.
47. Rossing K, Mischak H, Parving HH, Christensen PK, Walden M, Hillmann M, Kaiser T. Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns. Kidney Int. 2005;68:193-205.
48. Schiffer E, Mischak H, Vanholder RC. Exploring the uremic toxins using proteomic technologies. Contrib Nephrol. 2008; 160:159-171.
49. Sarto C, Deon C, Doro G, Hochstrasser DF, Mocarelli P, Sanchez JC. Contribution of proteomics to the molecular analysis of renal cell carcinoma with an emphasis on manganese superoxide dismutase. Proteomics. 2001;1:1288-1294.
50. Celis JE, Ostergaard M, Rasmussen HH, Gromov P, Gromova I, Varmark H, et al. A comprehensive protein resource for the study of bladder cancer. Electrophoresis. 1999;20:300-309.
51. Kim HJ, Sohng I, Hwang CH, Park JY. Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Int J Urol. 2006; 13(2):142-147.
52. Tolson JP, Flad T, Gnau V, Dihazi H, Hennenlotter J, Beck A, et al. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Proteomics. 2006;6: 697-708.
53. Rasmussen HH, Orntoft TF, Wolf H, Celis JE. Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J Urol. 1996;155:2113-2119.